ATE447025T1 - Ionenkanalaktivität hemmende niedrigmolekulare peptide - Google Patents

Ionenkanalaktivität hemmende niedrigmolekulare peptide

Info

Publication number
ATE447025T1
ATE447025T1 AT04723309T AT04723309T ATE447025T1 AT E447025 T1 ATE447025 T1 AT E447025T1 AT 04723309 T AT04723309 T AT 04723309T AT 04723309 T AT04723309 T AT 04723309T AT E447025 T1 ATE447025 T1 AT E447025T1
Authority
AT
Austria
Prior art keywords
low molecular
ion channel
polypeptides
channel activity
molecular peptides
Prior art date
Application number
AT04723309T
Other languages
English (en)
Inventor
Takane Yokotagawa
Masahiro Sokabe
Toshio Furuya
Original Assignee
Pharmadesign Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadesign Inc filed Critical Pharmadesign Inc
Application granted granted Critical
Publication of ATE447025T1 publication Critical patent/ATE447025T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04723309T 2003-03-26 2004-03-25 Ionenkanalaktivität hemmende niedrigmolekulare peptide ATE447025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003085666 2003-03-26
PCT/JP2004/004190 WO2004085647A1 (ja) 2003-03-26 2004-03-25 イオンチャネルの活性を阻害する低分子ペプチド

Publications (1)

Publication Number Publication Date
ATE447025T1 true ATE447025T1 (de) 2009-11-15

Family

ID=33095036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723309T ATE447025T1 (de) 2003-03-26 2004-03-25 Ionenkanalaktivität hemmende niedrigmolekulare peptide

Country Status (6)

Country Link
US (2) US7396816B2 (de)
EP (1) EP1609861B1 (de)
JP (1) JP4488522B2 (de)
AT (1) ATE447025T1 (de)
DE (1) DE602004023827D1 (de)
WO (1) WO2004085647A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320842D0 (en) * 2003-09-05 2003-10-08 Ionix Pharmaceuticals Ltd Ion channel modulators
WO2006014493A2 (en) * 2004-07-07 2006-02-09 The Research Foundation Of State University Of New York Stor Mechanically activated channel blocker
JP4654432B2 (ja) * 2004-11-08 2011-03-23 国立大学法人名古屋大学 機械受容（ＳｔｒｅｔｃｈＡｃｔｉｖａｔｅｄ）チャネルの活性化抑制剤
PL213159B1 (pl) 2010-04-23 2013-01-31 Inst Biolog Doswiadczalnej Im Marcelego Nenckiego Pan Zmutowane szczepy Escherichia coli, sposób testowania potencjalnych zwiazków antybakteryjnych wykorzystujacy te szczepy oraz zestaw do testowania
US9211313B2 (en) 2011-01-14 2015-12-15 The Research Foundation Of State University Of New York Methods and compound to inhibit Ca2+ permeable cation conductance
CA2830065A1 (en) 2011-03-16 2012-09-20 Amgen Inc. Potent and selective inhibitors of nav1.3 and nav1.7
JP2014084283A (ja) * 2012-10-19 2014-05-12 Univ Of Yamanashi 排尿障害治療薬
AR096927A1 (es) 2013-03-12 2016-02-10 Amgen Inc INHIBIDORES POTENTES Y SELECTIVOS DE NaV1.7
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
CN106632603B (zh) * 2016-12-09 2019-05-17 唐琼瑶 一组肽及其药物组合物和应用
US11612634B2 (en) 2020-12-11 2023-03-28 Xuzhou Medical University Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020077286A1 (en) * 2000-04-07 2002-06-20 Frederick Sachs Mechanically activated channel blocker

Also Published As

Publication number Publication date
JPWO2004085647A1 (ja) 2006-08-24
US20090181899A1 (en) 2009-07-16
EP1609861A4 (de) 2006-05-31
JP4488522B2 (ja) 2010-06-23
WO2004085647A1 (ja) 2004-10-07
EP1609861A1 (de) 2005-12-28
US7396816B2 (en) 2008-07-08
US20060229434A1 (en) 2006-10-12
DE602004023827D1 (de) 2009-12-10
EP1609861B1 (de) 2009-10-28

Similar Documents

Publication Publication Date Title
WO2003089457B1 (en) Peptide inhibitors of protein kinase c ϝ for pain management
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
EP1320541A4 (de) Tgf-beta inhibitoren und methoden
NO20023224L (no) DNA som koder for et biologisk aktivt fragment av baktericid/permeabilitetsökende protein, fremgangsmåte forfremstilling av dette, samt farmasöytisk preparat inneholdendedette
IN2014CN02050A (de)
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE447025T1 (de) Ionenkanalaktivität hemmende niedrigmolekulare peptide
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2002061076A1 (fr) Proteine associee a l'adiponectine
WO2003040370A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
ATE356140T1 (de) Gd3 mimetische peptide
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
WO2009020189A1 (ja) 血圧降下剤
ATE82984T1 (de) Hemmende peptide.
DE60225699D1 (de) Nierenspezifischer urattransporter und dessen gen
EP2072524A3 (de) Dipeptide und tripeptide mit anti-inflammatorischer wirkung
WO2004096832A3 (en) Novel antiangiogenic peptides
ATE405827T1 (de) Screening-verfahren
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
WO2005105838A3 (en) Ion channel
WO2003022300A1 (en) Preventives/remedies for bone/joint diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties